Amikar Sehdev

1.4k total citations
38 papers, 749 citations indexed

About

Amikar Sehdev is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Amikar Sehdev has authored 38 papers receiving a total of 749 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 12 papers in Cancer Research. Recurrent topics in Amikar Sehdev's work include Pancreatic and Hepatic Oncology Research (9 papers), Colorectal Cancer Treatments and Studies (7 papers) and Cancer Genomics and Diagnostics (7 papers). Amikar Sehdev is often cited by papers focused on Pancreatic and Hepatic Oncology Research (9 papers), Colorectal Cancer Treatments and Studies (7 papers) and Cancer Genomics and Diagnostics (7 papers). Amikar Sehdev collaborates with scholars based in United States and Canada. Amikar Sehdev's co-authors include Bert H. O’Neil, Daniel V.T. Catenacci, Safi Shahda, Blasé N. Polite, B. G. Vekhter, Ya‐Chen Tina Shih, Marc B. Bissonnette, Olufunmilayo I. Olopade, Yan Tong and Olumide B. Gbolahan and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Cancer.

In The Last Decade

Amikar Sehdev

37 papers receiving 743 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amikar Sehdev United States 16 437 229 229 174 136 38 749
Koichi Okamoto Japan 20 360 0.8× 342 1.5× 170 0.7× 156 0.9× 193 1.4× 86 927
Hai Lin China 16 236 0.5× 258 1.1× 128 0.6× 123 0.7× 132 1.0× 39 616
Fenglin Liu China 17 206 0.5× 289 1.3× 338 1.5× 180 1.0× 172 1.3× 53 801
Silvia Carpano Italy 14 388 0.9× 103 0.4× 210 0.9× 58 0.3× 96 0.7× 42 708
Yaokai Wen China 14 293 0.7× 249 1.1× 303 1.3× 139 0.8× 74 0.5× 45 788
Xiao‐Dong Jiao China 17 383 0.9× 291 1.3× 338 1.5× 213 1.2× 117 0.9× 56 821
Aizhen Cai China 15 162 0.4× 209 0.9× 161 0.7× 145 0.8× 131 1.0× 30 546
Qiongrong Chen China 12 390 0.9× 419 1.8× 84 0.4× 119 0.7× 84 0.6× 30 905
Kolitha Goonetilleke United Kingdom 9 574 1.3× 288 1.3× 113 0.5× 250 1.4× 345 2.5× 12 953

Countries citing papers authored by Amikar Sehdev

Since Specialization
Citations

This map shows the geographic impact of Amikar Sehdev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amikar Sehdev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amikar Sehdev more than expected).

Fields of papers citing papers by Amikar Sehdev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amikar Sehdev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amikar Sehdev. The network helps show where Amikar Sehdev may publish in the future.

Co-authorship network of co-authors of Amikar Sehdev

This figure shows the co-authorship network connecting the top 25 collaborators of Amikar Sehdev. A scholar is included among the top collaborators of Amikar Sehdev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amikar Sehdev. Amikar Sehdev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seçinti, Ekin, Shelley A. Johns, Wei Wu, et al.. (2023). Impact of acceptance and commitment therapy on physical and psychological symptoms in advanced gastrointestinal cancer patients and caregivers: Secondary results of a pilot randomized trial. Journal of Contextual Behavioral Science. 27. 107–115. 5 indexed citations
2.
Mosher, Catherine E., Ekin Seçinti, Kurt Kroenke, et al.. (2021). Acceptance and commitment therapy for fatigue interference in advanced gastrointestinal cancer and caregiver burden: protocol of a pilot randomized controlled trial. Pilot and Feasibility Studies. 7(1). 99–99. 8 indexed citations
3.
Gbolahan, Olumide B., Yan Tong, Amikar Sehdev, Bert H. O’Neil, & Safi Shahda. (2019). Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: a retrospective study. BMC Cancer. 19(1). 468–468. 30 indexed citations
4.
Sehdev, Amikar, et al.. (2019). Chronic inflammatory demyelinating polyradiculoneuropathy secondary to immune checkpoint inhibitors in melanoma patients.. PubMed. 28(152). 107–111. 10 indexed citations
5.
Joshi, Smita S., Daniel V.T. Catenacci, Theodore Karrison, et al.. (2019). Clinical Assessment of 5-Fluorouracil/Leucovorin, Nab-Paclitaxel, and Irinotecan (FOLFIRABRAX) in Untreated Patients with Gastrointestinal Cancer Using UGT1A1 Genotype–Guided Dosing. Clinical Cancer Research. 26(1). 18–24. 9 indexed citations
6.
DeWitt, John M., Kumar Sandrasegaran, Bert H. O’Neil, et al.. (2018). Phase 1 study of EUS-guided photodynamic therapy for locally advanced pancreatic cancer. Gastrointestinal Endoscopy. 89(2). 390–398. 74 indexed citations
7.
Milgrom, Daniel P., Amikar Sehdev, Joshua K. Kays, & Leonidas G. Koniaris. (2018). Integrating therapies for surgical adult soft tissue sarcoma patients. Translational Gastroenterology and Hepatology. 3. 88–88. 2 indexed citations
8.
Sehdev, Amikar, Theodore Karrison, Yuanyuan Zha, et al.. (2018). A pharmacodynamic study of sirolimus and metformin in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 82(2). 309–317. 14 indexed citations
9.
Bekaii‐Saab, Tanios, Alexander Starodub, Bassel F. El‐Rayes, et al.. (2017). A phase 1b/II study of cancer stemness inhibitor napabucasin in combination with gemcitabine (gem) & nab-paclitaxel (nabptx) in metastatic pancreatic adenocarcinoma (mpdac) patients (pts). Annals of Oncology. 28. iii150–iii150. 3 indexed citations
10.
Shahda, Safi, et al.. (2017). Impact of Nab–Paclitaxel-based Second-line Chemotherapy in Metastatic Pancreatic Cancer. Anticancer Research. 37(10). 5533–5539. 11 indexed citations
11.
Sehdev, Amikar, Eric A. Sherer, Siu L. Hui, Jingwei Wu, & David A. Haggstrom. (2017). Patterns of computed tomography surveillance in survivors of colorectal cancer at Veterans Health Administration facilities. Cancer. 123(12). 2338–2351. 6 indexed citations
12.
Sehdev, Amikar, et al.. (2016). Pathological complete response with anti-PD-1 therapy in a patient with microsatellite instable high, BRAF mutant metastatic colon cancer: a case report and review of literature.. PubMed. 21(117). 341–7. 19 indexed citations
13.
Sehdev, Amikar & Bert H. O’Neil. (2015). The Role of Aspirin, Vitamin D, Exercise, Diet, Statins, and Metformin in the Prevention and Treatment of Colorectal Cancer. Current Treatment Options in Oncology. 16(9). 43–43. 17 indexed citations
14.
Valsangkar, Nakul P., Amikar Sehdev, Subhasis Misra, et al.. (2015). Current management of gastrointestinal stromal tumors: Surgery, current biomarkers, mutations, and therapy. Surgery. 158(5). 1149–1164. 50 indexed citations
15.
Sehdev, Amikar, Ya‐Chen Tina Shih, B. G. Vekhter, et al.. (2014). Metformin for primary colorectal cancer prevention in patients with diabetes: A case‐control study in a US population. Cancer. 121(7). 1071–1078. 77 indexed citations
16.
Sehdev, Amikar & Daniel V.T. Catenacci. (2013). Perioperative therapy for locally advanced gastroesophageal cancer: current controversies and consensus of care. Journal of Hematology & Oncology. 6(1). 66–66. 15 indexed citations
17.
Sehdev, Amikar & Abhijeet Dhoble. (2010). Pulmonary artery dissection (PAD): A very unusual cause of chest pain. Journal of Hospital Medicine. 5(5). 313–316. 6 indexed citations
18.
Dougherty, Urszula, Masha Kocherginsky, Amikar Sehdev, et al.. (2009). Epidermal Growth Factor Receptor Is Required for Colonic Tumor Promotion by Dietary Fat in the Azoxymethane/Dextran Sulfate Sodium Model: Roles of Transforming Growth Factor- and PTGS2. Clinical Cancer Research. 15(22). 6780–6789. 30 indexed citations
19.
Dougherty, Urszula, Amikar Sehdev, Sandra Cerda, et al.. (2008). Epidermal Growth Factor Receptor Controls Flat Dysplastic Aberrant Crypt Foci Development and Colon Cancer Progression in the Rat Azoxymethane Model. Clinical Cancer Research. 14(8). 2253–2262. 48 indexed citations
20.
Fichera, Alessandro, Sujatha Jagadeeswaran, Urszula Dougherty, et al.. (2007). Epidermal Growth Factor Receptor Signaling Is Required for Microadenoma Formation in the Mouse Azoxymethane Model of Colonic Carcinogenesis. Cancer Research. 67(2). 827–835. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Koichi Okamoto Breakdown of academic impact, for papers by Hai Lin Breakdown of academic impact, for papers by Fenglin Liu Breakdown of academic impact, for papers by Silvia Carpano Breakdown of academic impact, for papers by Yaokai Wen Breakdown of academic impact, for papers by Xiao‐Dong Jiao Breakdown of academic impact, for papers by Aizhen Cai Breakdown of academic impact, for papers by Qiongrong Chen Breakdown of academic impact, for papers by Kolitha Goonetilleke
Rankless by CCL
2026